FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to pediatrics, and can be applied for treatment, prevention or reduction of systemic inflammatory in children at artificial feeding to level, which occurs at breast-feeding. For this purpose to child introduced is therapeutically efficient quantity of Lactobacillus rhamnosus GG (LGG) in combination with, at least, one long-chain polyunsaturated fatty acid (LCPUFA).
EFFECT: introduction of LGG and LCPUFA combination makes it possible to reduce systemic release of pro-inflammatory cytokines, chemokines and MPO considerably, conditioning efficiency of claimed therapy.
14 cl, 7 ex, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING OR PREVENTING SYSTEMIC INFLAMMATION | 2008 |
|
RU2468808C2 |
BABY FOOD CONTAINING INACTIVATED POWDER | 2008 |
|
RU2468807C2 |
COMPLETELY BALANCED IN NUTRITIONAL VALUE PREPARATION FOR BABIES, PROBIOTIC BABY FOOD AND METHOD OF REDUCTION OR PREVENTION OF INFLAMMATION IN BABY OR CHILD | 2009 |
|
RU2520085C2 |
METHOD FOR LEAN MUSCLE MASS GAIN AND FATTY TISSUE REDUCTION | 2007 |
|
RU2456985C2 |
APPLICATION OF POLYDEXTROSE FOR PREPARING MILK MIXTURES FOR CHILDREN ON ARTIFICIAL FEEDING | 2006 |
|
RU2415674C2 |
BABY FORMULA FOR ALIMENTATION OF INFANTS BEGINNING WITH FIRST MONTHS OF THEIR LIVES | 2004 |
|
RU2346448C2 |
NUTRITIONAL COMPOSITION CONTAINING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE | 2020 |
|
RU2818570C2 |
IMMUNITY-STIMULATING BABY FOOD | 2005 |
|
RU2426549C2 |
USE OF LGG FOR PREVENTION OR TREATMENT OF RESPIRATORY ALLERGIES | 2006 |
|
RU2435598C2 |
POWDERED BABY MILK | 2006 |
|
RU2405351C2 |
Authors
Dates
2011-04-20—Published
2006-03-22—Filed